ABOUT IAPAC | CONTACT | IAPAC HOME
 

TasP PrEP EVIDENCE SUMMIT

2014

2013

2012

 

Controlling the HIV Epidemic with Antiretrovirals: Avoiding the Cost of Inaction

18-19 September 2014 • Royal Garden Hotel, London

Sponsor and Partner Logos

GENERAL INFORMATION
The International Association of Providers of AIDS Care (IAPAC), in partnership the AIDS Healthcare Foundation (AHF), Public Health England (PHE), and the Joint United Nations Programme on HIV/AIDS (UNAIDS), recently hosted theControlling the HIV Epidemic with Antiretrovirals: Avoiding the Cost of Inaction summit, which took place 18-19 September 2014, at the Royal Garden Hotel in London.

The summit featured data related to and discussion about the implementation of combination prevention, including treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP), and provided a forum for exploring HIV care and prevention continua optimization to achieve antiretroviral therapy's maximum therapeutic and preventative effects.

PROGRAM
The summit was co-chaired by Kenneth H. Mayer, MD (Harvard University/Fenway Institute, USA) and Julio S.G. Montaner, MD (British Columbia Centre for Excellence in HIV/AIDS, Canada).

This year’s summit program built upon the significant momentum gained from the 2012 and 2013 summits. The 2012 summit allowed IAPAC to generate a Consensus Statement released at the XIX International AIDS Conference in Washington, DC, USA. And, last year’s summit is the subject of a 1 July 2014, IAPAC-sponsored supplement to Clinical Infectious Diseases. Featured in the supplement is an editorial (available as an Open Access manuscript) that served as the foundation for the 2014 summit program.

PRESENTATIONS
Select presentations from the 2014 summit appear below. IAPAC requests that any use of these presentations should include citations to both the presenting authors and relevant summit information (e.g. Controlling the HIV Epidemic with Antiretrovirals: Avoiding the Cost of Inaction, 18-19 September 2014, London).

 

THURSDAY, 18 September 2014

CONFERECE WELCOME
José M. Zuniga, PhD, MPH
Julio S.G. Montaner, MD
Kenneth H. Mayer, MD

KEYNOTE ADDRESS: Leveraging HIV Treatment to End AIDS, Stop New HIV Infections, and Avoid the Cost of Inaction
Michel Sidibé, MEcon

HIGH-LEVEL ROUNDTABLE: 90-90-90: The Final Treatment Targets toward the End of the AIDS Epidemic
Moderator: Lord Norman Fowler
Panelists:
Michel Sidibé, MEcon
Hon. Dr. Jean Kalilani
Hon. Sen. Sibongile Ndlela-Simelane
Deborah Birx, MD
Hon. Gordon Campbell
Matthias Schuppe
Kenly Sikwese
NOTE: This Roundtable discussion is sponsored by the Joint United Nations Programme on HIV/AIDS (UNAIDS).

PLENARY 1: Seizing an Historic Opportunity - A Response Based on Sound Science and Fundamental Human Rights
Deborah Birx, MD

PANEL 1: Controlling the HIV Epidemic - Perspectives on Turning Aspiration into Reality
Moderator: Celso Ramos, MD, MSc
Presenter: David M. Serwadda, MBChB, MMed, MSc, MPH
Discussants:
Wafaa El-Sadr, MD, MPH
Bohdan Nosyk, PhD
Fábio Mesquita, MD, PhD
Alan Whiteside, DEcon

PANEL 2: Ending Pediatric AIDS - Translating Hope into Reality
Click here to watch an introductory video. (Right-click to download — M4V file, 20MB)
Moderator: Charles Lyons
Panelists:
Deborah Birx, MD
Phillipe Duneton, MD
Anja Giphart, MD, MPH
Peter McDermott, MS, RPN
Badara Samb, MD, PhD
NOTE: This Panel discussion is sponsored by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF).

PLENARY 2: Optimizing the HIV Treatment Continuum
Meg Doherty, MD, PhD

PANEL 3: Testing and Linkage to Care as Gateways (or Closed Doors) to Successful HIV Control
Moderator: Jorge Saavedra, MD
Presenter: Wafaa El-Sadr, MD, MPH
Discussants:
Terri M. Ford
James McIntyre, MD
Kenly Sikwese
Rupert Whitaker, MD

PANEL 4: State-of-the-Science: Treatment as Prevention and/or Treatment for Treatment?
Moderator: Jane Anderson, MBBS, PhD
Presenter: Reuben Granich, MD, MPH
Discussants:
K. Rivet Amico, PhD
Nikos Dedes
Sarah J. Fidler, MBBS, PhD
Paula Munderi, MD

 
ORAL ABSTRACT SESSION 1: Treatment as Prevention
88 - Gaps in Care among Adults Receiving HIV Care in Western Kenya
Beth Rachlis presenting

94 - A Population-Based Public Health Approach: Population- versus Facility-Level Metrics for Measuring Engagement within the HIV Care Cascade
Becky Genberg presenting

111 - Monitoring Effectiveness of HIV Programs in the Era of Implementation Science Utilizing a Sample of 27,000 Drug Users and Men who have Sex with Men in India
Sunil Solomon presenting

Implementation of a Near Real-time Phylogenetic Monitoring Program for HIV Transmission Outbreaks
Art FY Poon presenting

 
PLENARY 3: Health Systems Strengthening
Francesca Celletti, MD

PLENARY 4: Community Engagement
Anna Zakowicz, MPH, MA

PLENARY 5: Stigma/Discrimination
Sean Strub
Click here to watch a video presentation. (Right-click to download — MP4 file, 160MB)>

PANEL 5: Harmonizing Global Treatment Initiation - The Tale of Varied Color Starting Flags
Moderator: David Asboe, MD
Presenter: Julio S.G. Montaner, MD
Discussants:
Serge Eholie, MD, PhD
Fábio Mesquita, MD, PhD
Andrew Phillips, PhD, MSc
Luis Soto-Ramirez, MD

 

FRIDAY, 19 September 2014

PLENARY 6: A Paradigm Shift Focused on the HIV Prevention Continuum
Richard Hayes, MSc, DSc

PANEL 6: State-of-the-Evidence: Antiretroviral Chemoprophylaxis
Moderator: James Rooney, MD
Presenter: Kenneth H. Mayer, MD
Discussants:
Richard Gilson, MD
Beatriz Grinsztejn, MD, PhD
Andrew Grulich, MBBS, PhD
Patrick Oyaro, MBChB

PLENARY 7: Striving for an Expanded HIV Prevention Response - What Does the Future Hold?
Sheryl Zwerski, RN

 
ORAL ABSTRACT SESSION 2: Pre-Exposure Prophylaxis
106 - Estimating the Impact of a PrEP Program in England for Men who have Sex with Men
Anthony Nardone presenting

109 - Using Mathematical Models to Estimate the Potential Impact of PrEP for Female Sex Workers and Men who have Sex with Men in Bangalore, India
Kate Mitchell presenting

114 - Civil Society Advocacy as a Prerequisite for the Implementation of Oral PrEP and other ARV-Based Prevention
Cindra Feuer presenting

117 - Stigma as Possible Barrier to PrEP Acceptance in Nigeria: Lessons Learned from the Formative Study on PrEP Acceptability
Nancin Dadem presenting

 
ORAL ABSTRACT SESSION 3: Treatment/Prevention Continua

75 - Perinatally HIV-Infected Young Adults Welcome PrEP and Envision its Potential in Curtailing the Epidemic
Silvia Rabionet presenting

93 - A Comparison of Clients Using National Online HIV Self-Sampling Services with Those Testing for HIV in STI Clinics in England, 2013
Samantha Westrop presenting

95 - Can the HIV Epidemic Be Eliminated in South Africa using Combination Prevention? A Modeling Analysis
Nadia N. Abuelezam presenting

103 - The “Undetectables” – Using Financial Incentives to Support Viral Load Suppression in a Community-Based Organization Providing Integrated Care
Virginia Shubert presenting

 
PANEL 7: Placing PrEP in Perspective - Ethical, Sociological, and Community Views
Moderator: Julie Barroso, PhD, ANP-BC, RN
Presenter: Jeremy Sugarman, MD, MPH
Discussants:
Sheldon Fields, PhD, ARNP
Jim Pickett
Midnight Poonkasetwattana, MSc
Janet Seeley, PhD

PLENARY 8: The 90-90-90 Target: A Smart and Doable Investment
Badara Samb, MD, PhD

PLENARY 9: Innovations in Health Service Delivery
Benjamin Young, MD, PhD

PLENARY 10: Pursuing Strategic Partnerships to Push Innovation
Bertrand Audoin, MBA

PLENARY 11: Innovative Health Financing
David Wilson, PhD

PLENARY 12: ROI Scenarios - Implications of Making Small-, Mid-, and Large-Scale Investments
Alan Whiteside, DEcon

CLOSING PANEL: Making It Happen - Navigating the Intersection of the HIV Care and Prevention Continua
Moderator: José M. Zuniga, PhD, MPH
Presenters:
Kenneth H. Mayer, MD
Julio S.G. Montaner, MD
Discussants:
Jane Anderson, MBBS, PhD
Patrick Oyaro, MBChB
Jorge Sánchez, MD
Kenly Sikwese

 

Summit Program
Click the image below to download the Summit Program and Oral Abstracts in PDF format.

TasP PreP 2014 Summit Program

Requires free Acrobat Reader Plugin Software
Get Adobe Reader

 

 
line
©2014 International Association of Physicians in AIDS Care. All Rights Reserved.